EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD
- 4 July 1964
- journal article
- Published by Elsevier in The Lancet
- Vol. 284 (7349), 10-12
- https://doi.org/10.1016/s0140-6736(64)90005-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of Corticosteroid Therapy on Fibrinolysis in Patients With Inflamatory and Non-inflammatory ConditionsBMJ, 1964
- Norethynodrel and ThromboembolismNew England Journal of Medicine, 1963
- Oral Contraception and Blood CoagulabilityBMJ, 1963
- Selective Inhibition in Human Pregnancy Blood of Urokinase Induced EibrinolysisScandinavian Journal of Clinical and Laboratory Investigation, 1963
- The inhibition of monoamine oxidase by arylalkylhydrazinesBiochemical Journal, 1962
- ORAL CONTRACEPTIVES: AN ASSESSMENT OF THEIR MODE OF ACTIONThe Lancet, 1962
- Variations in Non‐Specific Activation of Fibrinolytic System in Sera of Different SpeciesActa Pharmacologica et Toxicologica, 1962
- A Fibrinolytic System in Human Plasma Activated by Peptone or Acid PolysaccharidesScandinavian Journal of Clinical and Laboratory Investigation, 1961
- The Fibrinolytic System in Human Blood, as Exemplified in a Case of Agammaglobulinemia and a Case of MacroglobulinemiaScandinavian Journal of Clinical and Laboratory Investigation, 1960
- The fibrin plate method for estimating fibrinolytic activityArchives of Biochemistry and Biophysics, 1952